Technological offer portfolio

CSIC has specific technological results protected in very different ways, among which the patent prevails. The collaboration with companies interested in a protected asset can be realized in two different ways:

  1. An agreement for the development of technology (increase in TRL) with the option of a subsequent exploitation license.
  2. A license agreement for the protected asset leading to its commercial exploitation


computer

If you are interested in any of the technological offers, download the summary in pdf. For more information, contact the responsible technician who appears in it. If you look for general information about the technological offer or the technological capabilities of the research groups go to the "Marketing of RDI products" section.

Search for a technological offer

Oferta Tecnológica
NEW DNA SARS-COV-2 VACCINE
PEPTIDES FOR THE TREATMENT OF RETINITIS PIGMENTOSA
NEW VACCINE AGAINST MERS-COV BASED ON RNA REPLICONS
NUEVA VACUNA CONTRA MERS-COV BASADA EN REPLICONES DE ARN
NANOPARTICLES AS CONTRAST AGENTS FOR HIGH FIELD MAGNETIC RESONANCE IMAGING
NANOPARTÍCULAS COMO AGENTES DE CONTRASTE PARA LA OBTENCIÓN DE IMÁGENES POR RESONANCIA MAGNÉTICA DE ALTO CAMPO
ACYLATED DERIVATE OF PHLORETIN WITH INCREASED PERCUTANEOUS ABSORPTION
DERIVADO ACILADO DE FLORETINA CON MAYOR ABSORCIÓN PERCUTÁNEA
REMOVAL OF BEESWAX CONTAMINANTS
ELIMINACIÓN DE CONTAMINANTES DE CERA DE ABEJA

Contact:

If you are interested in one of the technology offers, please download the summary in pdf. For more information, contact with the technician responsible that appears on it. For general information on the technological offer or the research group’s technological capacities, please contact the Commercialisation Department.